Non-randomized Comparison between Neurofibromatosis Type 1 (NF1) and Non-NF1 Children Who Received Carboplatin and Vincristine (CV) for Progressive Low Grade Glioma (LGG): a Report from the Children’s Oncology Group (COG)

PURPOSE: To evaluate tumor response, event-free survival (EFS), overall survival (OS), and toxicity of chemotherapy, children with NF1 and progressive low-grade gliomas (LGG) were enrolled on COG A9952 protocol and treated with carboplatin and vincristine (CV). PATIENTS AND METHODS: Non-NF1 patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Ater, Joann L., Xia, Caihong, Mazewski, Claire M., Booth, Timothy N., Freyer, David R., Packer, Roger J., Sposto, Richard, Vezina, Gilbert, Pollack, Ian F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4892942/
https://ncbi.nlm.nih.gov/pubmed/27061921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29987
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares